Abstract: An external fixation system for treatment of bones includes first and second clamps for locking pins that are inserted into bones. At least one clamp includes a socket having a recess. An attachment post includes a distal portion configured to be inserted into the socket recess. A tightening nut is rotationally coupled to a shaft of the attachment post and has an internal threading adapted to be threaded to the external threading of the socket. When the tightening nut is rotated to cause the distal portion of the post to be further inserted into the recess, the sides of the distal portion of the post create an interference fit with the sides of the socket recess to lock the post to the first clamp.

Abstract: A bonded optical assembly comprising infrared-transparent materials. The assembly comprises two or more infrared transparent optical elements and a polymer comprising at least one chalcogenide element and crosslinking moieties between the infrared-transparent optical elements. The crosslinking moieties may be organic, inorganic, or both.

Abstract: This application relates generally to an optical fiber for the delivery of infrared light where the polarization state of the light entering the fiber is preserved upon exiting the fiber and the related methods for making thereof. The optical fiber has a wavelength between about 0.9 ?m and 15 ?m, comprises at least one infrared-transmitting glass, and has a polarization-maintaining (PM) transverse cross-sectional structure. The infrared-transmitting, polarization-maintaining (IR-PM) optical fiber has a birefringence greater than 10?5 and has applications in dual-use technologies including laser power delivery, sensing and imaging.

Abstract: A device for vaporizing a composition. The device comprises a thermally conductive substrate having a surface, the surface comprising a thermally conductive surface structure. A dry composition capable of a solid to liquid phase change upon being heated to at least a select temperature is disposed on the surface structure. The surface structure is configured to form liquid droplets of the composition upon heating of the surface structure to at least the select temperature. The liquid droplets have a median diameter less than a median diameter of liquid droplets formed on a planar substrate surface heated to at least the select temperature.

Abstract: Drug supply units are disclosed which comprise substrates having a plurality of holes formed therein.

Abstract: Drug supply units are disclosed which comprise substrates having a plurality of holes formed therein.

Abstract: The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.

Abstract: The disclosure teaches the use of antistatic materials in the airway for thermal aerosol generation devices. The present disclosure teaches the use of antistatic materials for drug delivery in any drug that may be susceptible to charging during aerosol generation.

Abstract: The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.

Abstract: A mobile computing device includes one or more interfaces to connect to one or more devices, and one or more processing devices, connected with the one or more interfaces. The one or more processing devices are to establish a first wireless connection with a first device. The first device lacks resources to connect to a cloud service directly. The one or more processing devices are also to receive data from the first device, provide the data to the cloud service, and in response to detecting a migration condition, disconnect the first wireless connection to allow establishment of a second wireless connection between the first device and a second device such that the second device receives subsequent data from the first device and provides the subsequent data to the cloud service.

Abstract: In embodiments, a device control application reads a configuration file responsive to a first execution of the device control application on a mobile device. The mobile device parses the first configuration file to identify one or more supported devices, managed properties of each of the one or more supported devices, actions that indicate information about the managed properties, and controls associated with at least one of the one or more supported devices or the one or more managed properties, wherein a control causes a specified user input to generate a command to cause a managed property to have a specified value. The mobile device crates a first version of the device control application based on the configuration file during runtime of the device control application based on a result of the parsing. The mobile device then presents the first version of the device control application.

Abstract: The disclosure teaches the use of antistatic materials in the airway for thermal aerosol generation devices. The present disclosure teaches the use of antistatic materials for drug delivery in any drug that may be susceptible to charging during aerosol generation.

Abstract: In embodiments, a processing device receives an identification of a source code file for a device control application and an associated configuration file for the device control application. The processing device parses the configuration file to identify a first set of classes that are specified in the configuration file but that are not specified in the source code file. The processing device analyzes the source code file to identify a second set of classes that are specified in the source code file. The processing device retrieves the first set of classes and the second set of classes from a library, wherein classes from the library other than the first set of classes and the second set of classes are not retrieved. The processing device generates an executable file for the device control application based on the source code file, the first set of classes and the second set of classes.

Abstract: Drug supply units are disclosed which comprise substrates having a plurality of holes formed therein.

Abstract: A method includes establishing, by a processing device of a first device, a first connection with a second device. The first connection including a first connection type. The method includes detecting a network change event. The network change event including a change in connection status of at least one of the first connection type or a second connection type. The method includes determining an available connection type having a highest rank responsive to detecting the network change event. In response to a determination that the available connection type having the highest rank is the second connection type or a third connection type, the method includes establishing a second connection with the second device. The second connection including the available connection type having the highest rank. The method includes communicating with the second device using the available connection type having the highest rank via the second connection.

Abstract: Drug supply units are disclosed which comprise substrates having a plurality of holes formed therein.

Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.

Abstract: In embodiments, a device control application reads a configuration file responsive to a first execution of the device control application on a mobile device. The mobile device parses the first configuration file to identify one or more supported devices, managed properties of each of the one or more supported devices, actions that indicate information about the managed properties, and controls associated with at least one of the one or more supported devices or the one or more managed properties, wherein a control causes a specified user input to generate a command to cause a managed property to have a specified value. The mobile device crates a first version of the device control application based on the configuration file during runtime of the device control application based on a result of the parsing. The mobile device then presents the first version of the device control application.

Abstract: In embodiments, a processing device receives an identification of a source code file for a device control application and an associated configuration file for the device control application. The processing device parses the configuration file to identify a first set of classes that are specified in the configuration file but that are not specified in the source code file. The processing device analyzes the source code file to identify a second set of classes that are specified in the source code file. The processing device retrieves the first set of classes and the second set of classes from a library, wherein classes from the library other than the first set of classes and the second set of classes are not retrieved. The processing device generates an executable file for the device control application based on the source code file, the first set of classes and the second set of classes.

Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.